Fennec Pharmaceuticals (RV41.F) Q2 2025 Earnings

13MayConfirmed
Q3 2024
Q4 2024
Q1 2025
Q2 2025
-0.2
-0.14
-0.08
-0.02

Details

Expected EPS
-0.0788040724897796
Actual EPS
-0.034721156425925596
Surprise EPS
0.04
Surprise Percent
+55.94%

Description

Fennec Pharmaceuticals (RV41.F) has reported earnings of -0.034721156425925596 per share for Q2 2025.

0 Comments

Share your thoughts